FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3086341289> ?p ?o ?g. }

• W3086341289 abstract "In patients with relapsing polychondritis (RP), organ involvement developed in those with progressive and/or long disease courses. For their management, elucidation of a subgroup suggesting disease progression is awaited.We previously conducted a physician's questionnaire-based retrospective study to elucidate major clinical features of Japanese patients with RP. We here evaluated organ involvement at disease onset and at the last follow-up. We then counted cumulative numbers of involved organs at the last follow-up in 229 RP patients and compared them with involved organ numbers at disease onset, as possible indicators of disease progression. We assigned their prognosis at the last follow-up into patient prognostic stages from no medication (stage 1) to death (stage 5). We utilized nonparametric tests for group comparisons.Involved organ numbers per-patient were 1.13 ± 0.03 at disease onset and 3.25 ± 0.10 at the last follow-up (disease duration was 4.69 ± 0.33 years), and increased along with the patient prognostic stages.At disease onset, 135 and 48 patients had auricular involvement (59% of 229 patients, defined as auricular-onset subgroup; AO) and respiratory involvement (21%, respiratory-onset subgroup; RO), respectively. 46 patients presented with other conditions (20%, miscellaneous-onset subgroup; MO) including CNS, ocular, and inner ear involvement, among others.RO patients showed worse (poorer) prognostic stages than AO patients. MO patients developed respiratory and/or auricular involvement thereafter and then showed significantly higher mortality rate (15%; 7/46) than AO patients (5.9%; 8/135).In RP patients who did not develop respiratory involvement until the last follow-up (throughout the disease course; 117 patients), mortality rate was 19% in 26 MO patients and 3.3% in 91 AO patients. Accordingly, RO patients and MO patients associated with relatively poor prognosis compared with AO patients.Allocation of patients to RO and MO subgroups was suggested to associate with poorer prognosis of RP than AO subgroups, especially AO subgroups without respiratory involvement throughout. All RP patients deserve careful monitoring but special attention should be paid to MO patients because of their diverse and accelerated disease progression." @default.
• W3086341289 created "2020-09-21" @default.
• W3086341289 creator A5018436317 @default.
• W3086341289 creator A5047362472 @default.
• W3086341289 creator A5052024446 @default.
• W3086341289 creator A5070541553 @default.
• W3086341289 date "2020-09-11" @default.
• W3086341289 modified "2023-10-18" @default.
• W3086341289 title "Elucidation of predictors of disease progression in patients with relapsing polychondritis at the onset: potential impact on patient monitoring" @default.
• W3086341289 cites W15601188 @default.
• W3086341289 cites W1972986693 @default.
• W3086341289 cites W2005297525 @default.
• W3086341289 cites W2015600753 @default.
• W3086341289 cites W2020428382 @default.
• W3086341289 cites W2023048922 @default.
• W3086341289 cites W2028963181 @default.
• W3086341289 cites W2047089230 @default.
• W3086341289 cites W2061599933 @default.
• W3086341289 cites W2067554953 @default.
• W3086341289 cites W2105770843 @default.
• W3086341289 cites W2122545833 @default.
• W3086341289 cites W2126208494 @default.
• W3086341289 cites W2130844201 @default.
• W3086341289 cites W2137548712 @default.
• W3086341289 cites W2142577589 @default.
• W3086341289 cites W2144333906 @default.
• W3086341289 cites W2151570219 @default.
• W3086341289 cites W2169902619 @default.
• W3086341289 cites W2180898381 @default.
• W3086341289 cites W2211320648 @default.
• W3086341289 cites W2272555951 @default.
• W3086341289 cites W2288155519 @default.
• W3086341289 cites W2294289955 @default.
• W3086341289 cites W2308460192 @default.
• W3086341289 cites W2308925259 @default.
• W3086341289 cites W2322494774 @default.
• W3086341289 cites W2342489117 @default.
• W3086341289 cites W2404822445 @default.
• W3086341289 cites W2409846233 @default.
• W3086341289 cites W2467162074 @default.
• W3086341289 cites W2517379868 @default.
• W3086341289 cites W2549551963 @default.
• W3086341289 cites W2590009097 @default.
• W3086341289 cites W2599158324 @default.
• W3086341289 cites W2754285992 @default.
• W3086341289 cites W2759251462 @default.
• W3086341289 cites W2771675419 @default.
• W3086341289 cites W2803278890 @default.
• W3086341289 cites W2897143502 @default.
• W3086341289 cites W2901274393 @default.
• W3086341289 cites W2952002671 @default.
• W3086341289 cites W2962438494 @default.
• W3086341289 cites W2996463911 @default.
• W3086341289 cites W306902674 @default.
• W3086341289 cites W4293117573 @default.
• W3086341289 doi "https://doi.org/10.1186/s41927-020-00141-8" @default.
• W3086341289 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7488391" @default.
• W3086341289 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32944685" @default.
• W3086341289 hasPublicationYear "2020" @default.
• W3086341289 type Work @default.
• W3086341289 sameAs 3086341289 @default.
• W3086341289 citedByCount "8" @default.
• W3086341289 countsByYear W30863412892021 @default.
• W3086341289 countsByYear W30863412892022 @default.
• W3086341289 countsByYear W30863412892023 @default.
• W3086341289 crossrefType "journal-article" @default.
• W3086341289 hasAuthorship W3086341289A5018436317 @default.
• W3086341289 hasAuthorship W3086341289A5047362472 @default.
• W3086341289 hasAuthorship W3086341289A5052024446 @default.
• W3086341289 hasAuthorship W3086341289A5070541553 @default.
• W3086341289 hasBestOaLocation W30863412891 @default.
• W3086341289 hasConcept C10515644 @default.
• W3086341289 hasConcept C126322002 @default.
• W3086341289 hasConcept C141071460 @default.
• W3086341289 hasConcept C146357865 @default.
• W3086341289 hasConcept C151730666 @default.
• W3086341289 hasConcept C167135981 @default.
• W3086341289 hasConcept C187960798 @default.
• W3086341289 hasConcept C2777767895 @default.
• W3086341289 hasConcept C2777995143 @default.
• W3086341289 hasConcept C2779134260 @default.
• W3086341289 hasConcept C44249647 @default.
• W3086341289 hasConcept C534529494 @default.
• W3086341289 hasConcept C71924100 @default.
• W3086341289 hasConcept C86803240 @default.
• W3086341289 hasConceptScore W3086341289C10515644 @default.
• W3086341289 hasConceptScore W3086341289C126322002 @default.
• W3086341289 hasConceptScore W3086341289C141071460 @default.
• W3086341289 hasConceptScore W3086341289C146357865 @default.
• W3086341289 hasConceptScore W3086341289C151730666 @default.
• W3086341289 hasConceptScore W3086341289C167135981 @default.
• W3086341289 hasConceptScore W3086341289C187960798 @default.
• W3086341289 hasConceptScore W3086341289C2777767895 @default.
• W3086341289 hasConceptScore W3086341289C2777995143 @default.
• W3086341289 hasConceptScore W3086341289C2779134260 @default.
• W3086341289 hasConceptScore W3086341289C44249647 @default.
• W3086341289 hasConceptScore W3086341289C534529494 @default.
• W3086341289 hasConceptScore W3086341289C71924100 @default.
• W3086341289 hasConceptScore W3086341289C86803240 @default.
• W3086341289 hasFunder F4320321945 @default.

• next